Xiaohan Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiaohan Hu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- HuiWen Wu
Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing 210029, People’s Republic of China
1 shared publication - Jiali Xu
Laboratory Center for Basic Medical Sciences, Nanjing medical university Nanjing, 210029, PR China
1 shared publication - Jin Zhou
Department of General Surgery, The Nanjing First Hospital Affiliated to Nanjing Medical University, Nanjing 210006, PR China
1 shared publication - Jun Guo
Nanjing Medical University
1 shared publication - Xiao Han
Jiangsu Provincial Key Laboratory of Molecular Targets and Interventions for Metabolic Diseases, Department of Biochemistry and Molecular Biology, Nanjing Medical University 1 , Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 14 July 2009
- Published by Springer Nature in BMC Neuroscience
- Vol. 10 (1) , 74
Src kinase up-regulates the ERK cascade through inactivation of protein phosphatase 2A following cerebral ischemia
Background: The regulation of protein phosphorylation requires a balance in the activity of protein kinases and protein phosphatases. Our previous data indicates that Src can increase ERK activity through Raf kinase in response to ischemic stimuli. This study examined the molecular mechanisms by which Src activates ERK cascade through protein phosphatases following cerebral ischemia. Results: Ischemia-induced Src activation is followed by phosphorylation of PP2A at Tyr307 leading to its inhibition in the rat hippocampus. SU6656, a Src inhibitor, up-regulates PP2A activity, resulting in a significant decreased activity in ERK and its targets, CREB and ERα. In addition, the PP2A inhibitor, cantharidin, led to an up-regulation of ERK activity and was able to counteract Src inhibition during ischemia. Conclusion: Src induces up-regulation of ERK activity and its target transcription factors, CREB and ERα, through attenuation of PP2A activity. Therefore, activation of ERK is the result of a crosstalk between two pathways, Raf-dependent positive regulators and PP2A-dependent negative regulators.
- 14 July 2009
- Published by Springer Nature in BMC Neuroscience
- Vol. 10 (1) , 74
Open AccessSrc kinase up-regulates the ERK cascade through inactivation of protein phosphatase 2A following cerebral ischemia
Background: The regulation of protein phosphorylation requires a balance in the activity of protein kinases and protein phosphatases. Our previous data indicates that Src can increase ERK activity through Raf kinase in response to ischemic stimuli. This study examined the molecular mechanisms by which Src activates ERK cascade through protein phosphatases following cerebral ischemia. Results: Ischemia-induced Src activation is followed by phosphorylation of PP2A at Tyr307 leading to its inhibition in the rat hippocampus. SU6656, a Src inhibitor, up-regulates PP2A activity, resulting in a significant decreased activity in ERK and its targets, CREB and ERα. In addition, the PP2A inhibitor, cantharidin, led to an up-regulation of ERK activity and was able to counteract Src inhibition during ischemia. Conclusion: Src induces up-regulation of ERK activity and its target transcription factors, CREB and ERα, through attenuation of PP2A activity. Therefore, activation of ERK is the result of a crosstalk between two pathways, Raf-dependent positive regulators and PP2A-dependent negative regulators.